MetLife Investment Management’s ArcBest ARCB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.2M | Sell |
12,228
-763
| -6% | -$72.3K | 0.01% | 1313 |
|
|
2025
Q4 | $964K | Hold |
12,991
| – | – | ﹤0.01% | 1449 |
|
|
2025
Q3 | $908K | Sell |
12,991
-1,162
| -8% | -$87.4K | ﹤0.01% | 1502 |
|
|
2025
Q2 | $1.09M | Hold |
14,153
| – | – | 0.01% | 1259 |
|
|
2025
Q1 | $999K | Sell |
14,153
-230
| -2% | -$19.9K | 0.01% | 1365 |
|
|
2024
Q4 | $1.34M | Buy |
14,383
+782
| +6% | +$82.7K | 0.01% | 1264 |
|
|
2024
Q3 | $1.48M | Hold |
13,601
| – | – | 0.01% | 1178 |
|
|
2024
Q2 | $1.46M | Buy |
13,601
+1,516
| +13% | +$183K | 0.01% | 1140 |
|
|
2024
Q1 | $1.72M | Sell |
12,085
-518
| -4% | -$67.8K | 0.01% | 1026 |
|
|
2023
Q4 | $1.52M | Hold |
12,603
| – | – | 0.01% | 1087 |
|
|
2023
Q3 | $1.28M | Hold |
12,603
| – | – | 0.01% | 1113 |
|
|
2023
Q2 | $1.25M | Hold |
12,603
| – | – | 0.01% | 1144 |
|
|
2023
Q1 | $1.16M | Sell |
12,603
-410
| -3% | -$36.9K | 0.01% | 1150 |
|
|
2022
Q4 | $911K | Hold |
13,013
| – | – | 0.01% | 1266 |
|
|
2022
Q3 | $946K | Buy |
13,013
+745
| +6% | +$59.9K | 0.01% | 1217 |
|
|
2022
Q2 | $863K | Sell |
12,268
-1,410
| -10% | -$104K | 0.01% | 1291 |
|
|
2022
Q1 | $1.1M | Buy |
13,678
+4,871
| +55% | +$439K | 0.01% | 1269 |
|
|
2021
Q4 | $1.06M | Hold |
8,807
| – | – | 0.01% | 1106 |
|
|
2021
Q3 | $720K | Sell |
8,807
-1,644
| -16% | -$108K | 0.01% | 1309 |
|
|
2021
Q2 | $608K | Hold |
10,451
| – | – | 0.01% | 1453 |
|
|
2021
Q1 | $735K | Hold |
10,451
| – | – | 0.01% | 1300 |
|
|
2020
Q4 | $446K | Hold |
10,451
| – | – | ﹤0.01% | 1542 |
|
|
2020
Q3 | $325K | Hold |
10,451
| – | – | ﹤0.01% | 1588 |
|
|
2020
Q2 | $277K | Hold |
10,451
| – | – | ﹤0.01% | 1705 |
|
|
2020
Q1 | $183K | Hold |
10,451
| – | – | ﹤0.01% | 1747 |
|
|
2019
Q4 | $288K | Hold |
10,451
| – | – | ﹤0.01% | 1780 |
|
|
2019
Q3 | $318K | Hold |
10,451
| – | – | ﹤0.01% | 1674 |
|
|
2019
Q2 | $294K | Hold |
10,451
| – | – | ﹤0.01% | 1799 |
|
|
2019
Q1 | $322K | Hold |
10,451
| – | – | ﹤0.01% | 1717 |
|
|
2018
Q4 | $358K | Hold |
10,451
| – | – | ﹤0.01% | 1565 |
|
|
2018
Q3 | $507K | Sell |
10,451
-2,364
| -18% | -$111K | 0.01% | 1536 |
|
|
2018
Q2 | $586K | Hold |
12,815
| – | – | 0.01% | 1312 |
|
|
2018
Q1 | $411K | Hold |
12,815
| – | – | ﹤0.01% | 1481 |
|
|
2017
Q4 | $458K | Buy |
+12,815
| New | +$437K | 0.01% | 1445 |
|
Other funds holding ARCB
VPM
VCM
MetLife Investment Management's ARCB Position: Q1 2026 in Review
MetLife Investment Management reduced its ArcBest (ARCB) stake by 5.9% in Q1 2026, selling an estimated $72.3K and leaving 12,228 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #1313.
MetLife Investment Management first reported a position in ARCB in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.72M in Q1 2024. 277 funds tracked by Wall St. Rank hold ARCB as of Q1 2026.
- MetLife Investment Management held 12,228 shares of ArcBest worth $1.2M as of Q1 2026.
- MetLife Investment Management sold 763 ArcBest shares in Q1 2026, an estimated $72.3K.
- ArcBest made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1313 holding.
- MetLife Investment Management first reported a position in ArcBest in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's ArcBest position peaked at $1.72M in Q1 2024.
- 277 funds tracked by Wall St. Rank held ArcBest as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.